Overview

Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Ramipril 10 mg capsules under fasting conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Ramipril